ENOV Enovis Corporation
XNYS
20.81
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ENOV
$20.81
—
Key stats
$20.81
Pre-market
$20.81
+0.00%
- 52-Week Range
- $16.70 – $34.28
- YTD
- -21.50%
- IV Rank (30D)
- 56.69
- Straddle Price
- $3.33
- P/C Vol Ratio
- 0.12
- Market Cap
- $1.2B
- Open
- $20.66
- Day Range
- $20.48 – $21.49
- Volume
- 1,204,040
- Prev Close
- $20.69
Fair Value
+50.0% vs price
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 1.12 |
| Cost of Equity (CAPM) | 11.31% (VRP-adj) |
| WACC | 8.15% |
| Volatility Risk Premium | +56.2pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +6.2% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.06 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.1B |
| Return on Equity (TTM) | -74.6% |
| Book / Price | 124.1% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 61.1% |
| FCF Margin (TTM) | 2.8% |
| Debt / Equity | 0.84 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +14.9% (reverse-DCF on current price) |
| SMA 50 | $20.60 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $18.66 |
| Bollinger Width / SMA20 | 107.2% (drives anchor stability) |
| Net Debt | $1.2B |
| Market Cap | $1B |
Peers used for multiples: ABT, GMED, ITGR, MDT, MMSI, TFX
(filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$51.47
Deviation
+50.0%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $3.62 | 48% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 32.7× · 5 peers |
| Peer EV/EBITDA | $79.92 | 14% | median 17.0× · 6 peers |
| Peer P/B | $63.52 | 19% | median 2.5× · 6 peers |
| Peer P/S | $140.24 | 19% | median 3.3× · 6 peers |
| Market Anchor (SMA50) | $20.60 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $20.68 | 0% | 6 strikes · skew +0.51 |
As of 2026-10-22 · updated
Related
About
- Industry (SIC)
- ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES (3842) · industry map
- Exchange
- XNYS
- Market Cap
- $1.2B
- Employees
- 7,802
- List Date
- 2008-05-08
- CIK
- 0001420800
- Next Earnings
- 2026-11-05 (Pre-Market)
- EPS Forecast
- $0.64 (2 est.)
- Headquarters
- Lewisville, TX
- Homepage
- https://www.enovis.com
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, …
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|
| Jan | -- | 15.72% | 5.88% | 6.05% | -16.86% | 2.70% |
| Feb | -- | -10.63% | 0.34% | -14.62% | 14.88% | -2.51% |
| Mar | -- | -6.68% | 3.43% | 0.92% | -11.48% | -3.45% |
| Apr | -7.92% | 8.94% | -10.09% | -6.97% | 0.30% | -3.15% |
| May | 1.90% | -10.19% | -9.26% | -9.54% | -3.98% | -6.21% |
| Jun | -17.57% | 19.20% | -8.06% | 5.77% | -4.61% | -1.05% |
| Jul | 6.64% | 1.09% | 7.42% | -18.84% | 44.59% | 8.18% |
| Aug | -15.14% | -12.07% | 0.13% | 20.05% | -21.74% | -5.75% |
| Sep | -7.10% | -6.67% | -3.41% | -1.62% | -11.01% | -5.96% |
| Oct | 4.02% | -10.28% | -0.48% | 2.56% | 15.29%* | 2.22% |
| Nov | 9.24% | 9.84% | 15.04% | -3.54% | -- | 7.64% |
| Dec | -5.29% | 9.91% | -11.05% | -9.26% | -- | -3.92% |
| Total | -30.02% | 1.14% | -12.80% | -30.01% | -9.83% | -16.30% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $18.66
SMA 50: $20.60
SMA 200: $23.27
Current: $20.81
EMA 12: $19.37
EMA 26: $19.35
MACD: 0.0175 | Signal: 0.4911
BEARISH
ADX (14): 19.96
RANGE
+DI: 33.67
−DI: 14.95
Momentum Oscillators
RSI (14): 61.32
NEUTRAL
Stoch %K: 90.97
Stoch %D: 92.92
Williams %R: -14.20
Volume & Volatility
BB Upper: $20.52
BB Lower: $16.79
OVERBOUGHT
OBV: -21,178,072
Vol SMA 20: 1,411,482
Vol ROC: -7.66%
ATR: $0.92
True Range: $1.00
HV 20: 39.4%
HV 30: 45.1%
HV 60: 68.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-23T00:00:00 – 2026-10-21T00:00:00
AI Analysis
Here is my comprehensive stock analysis report for ENOV:
Executive Summary
Overall Assessment: BEARISH (Confidence Level: 6/10) Key Drivers: Technical indicators suggest a bearish trend, while recent news headlines are neutral to positive. Primary Risks: High volatility and potential technical breakdown.
Investment Thesis: ENOV's recent price action is driven by negative momentum, which could lead to further declines. However, the stock's beta suggests it may be more volatile than the broader market, making it a higher-risk investment.
Recent News Sentiment Impact: The recent news headlines are generally neutral or positive, which has not significantly impacted the stock's price movement.
Technical Analysis
Trend Direction: BEARISH (Short-term), BEARISH (Medium-term)
Support/Resistance Levels:
- Lower Bollinger Band: $19.47
- Upper Bollinger Band: $28.87
Momentum Signals:
- RSI Interpretation: Oversold (-25.52)
- MACD Signal: Bearish (Histogram: -0.84)
- Bollinger Bands Position: Oversold
Volume Analysis:
- Volume SMA 20: 1191338.54
- On-Balance Volume (OBV): -30049406.26
News & Sentiment Analysis
Recent Headlines Summary: Neutral to positive news headlines have not significantly impacted the stock's price movement.
Sentiment Assessment: Aggregate sentiment is NEUTRAL, with no strong bearish or bullish signals.
Catalyst Identification:
- No recent earnings reports or significant events
Market Narrative: Technical signals are driving the stock's price movement, while news headlines are neutral to positive.
Risk & Volatility Assessment
Risk Interpretation: High (Beta: 1.48)
Volatility Regime: Current volatility is higher than historical levels (HV30: 83.6%, HV60: 83.3%).
Options Market Signals:
- IV Rank: 26.9% (Medium)
- Put/Call Volume Ratio: 0.49 (Bullish sentiment)
- Market Expectation: Options market pricing a $3.55 move by expiration
Downside Protection:
- Lower Bollinger Band: $19.47
- Support levels and risk management considerations are critical in this high-volatility environment.
Market Context & Positioning
Sector Performance: ENOV is relatively weak compared to its sector (Healthcare Technology).
Institutional Activity: Volume patterns suggest institutional interest, but no strong buying or selling signals.
Correlation Analysis: The stock has a low correlation with the broader market (R-squared interpretation: 0.30).
Relative Valuation: ENOV is trading within a relatively narrow range compared to its historical volatility and technical indicators.
Key Levels & Action Items
Critical Price Levels:
- Lower Bollinger Band: $19.47
- Upper Bollinger Band: $28.87
Breakout/Breakdown Levels: None identified
Time-Sensitive Catalysts: No upcoming events or earnings reports that could significantly impact the stock's price movement.
Risk Management:
- Stop-loss levels should be set to protect against potential losses.
- Position sizing considerations are critical in this high-volatility environment.
Please note that this analysis is based on the provided data and may not reflect my personal opinion or investment advice.
Generated
News
All ENOV news →
Earnings History
14 of 15 under expected move
Avg Expected Move
11.15%
Avg Actual Move
6.47%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2022-11-02 | Pre-Market | 19.58% | 3.41% | 0.17x | Within |
| 2023-05-04 | Pre-Market | 7.23% | 1.67% | 0.23x | Within |
| 2023-08-03 | Pre-Market | 6.65% | 6.13% | 0.92x | Within |
| 2023-10-19 | Pre-Market | 6.31% | 7.49% | 1.19x | Exceeded |
| 2024-02-22 | Pre-Market | 8.59% | 5.86% | 0.68x | Within |
| 2024-05-02 | Pre-Market | 7.45% | 5.90% | 0.79x | Within |
| 2024-08-07 | Pre-Market | 12.39% | 3.36% | 0.27x | Within |
| 2024-11-06 | Pre-Market | 11.66% | 8.29% | 0.71x | Within |
| 2025-02-26 | Pre-Market | 11.58% | 4.99% | 0.43x | Within |
| 2025-05-08 | After-Close | 8.69% | 0.09% | 0.01x | Within |
| 2025-08-07 | Pre-Market | 13.98% | 10.71% | 0.77x | Within |
| 2025-11-06 | Pre-Market | 12.94% | 9.75% | 0.75x | Within |
| 2026-02-26 | Pre-Market | 14.45% | 13.89% | 0.96x | Within |
| 2026-05-07 | After-Close | 11.28% | 2.68% | 0.24x | Within |
| 2026-08-06 | Pre-Market | 14.50% | 12.82% | 0.88x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
ENOV Options Activity & IV Rank
ENOV IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 73.8%
7-DTE IV: —
Expected Move: $3.33
7-DTE Move: $3.33
Days to Exp: 30 (2026-11-20)
Options Flow
Call Volume: 946
Put Volume: 116
P/C Volume: 0.123
BULLISH
Call OI: 3,153
Put OI: 271
P/C OI: 0.086
Total OI: 3,424
ATM Options Pricing
ATM Call: $2.33
ATM Put: $1.00
Call %: 11.2%
Put %: 4.8%
Chain Summary
Chain Volume: 1,586
Chain OI: 12,531
Last Updated: 10/21/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 71st percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
71%
vs own history
GEX tilt
+0.44
OI-weighted, today
Vanna tilt
+0.49
δ-sensitivity to IV
Charm tilt
-0.63
δ-decay vs time
Vanna tilt +0.49: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.63: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 10 ATM contracts, 2k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 21 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 21 · ATM 69.0% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)56.7MediumOct 21
Straddle Price (30 DTE)$3.33Oct 21
Beta Analysis
Risk Metrics
Beta: 1.3719
Alpha: -44.52%
Correlation: 0.2757
R-Squared: 7.6%
Stock Volatility: 63.2%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own ENOV
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Oaktree Capital Asset manager Howard Marks | $37.8M | #43 of 130 | new | 13F | |
| Millennium Management Hedge fund Izzy Englander | $16.6M | #1247 of 3716 | +27.6% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $1.6M | #765 of 997 | +50.5% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $458K | #2128 of 4729 | +138.2% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ENOV Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 57,287,924 (as of 2026-07-03)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
7 filers$47.94M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | UBS Group AG Custodian | $32.66M | 68.12% | 2026-06-30 |
| 2 | Portman Square Capital LLP | $10.10M | 21.08% | 2026-09-30 |
| 3 | Susquehanna International Group, LLP Custodian | $3.72M | 7.77% | 2026-06-30 |
| 4 | Walleye Trading LLC | $1.15M | 2.40% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $213.21K | 0.44% | 2026-06-30 |
| 6 | GROUP ONE TRADING LLC Custodian | $89.01K | 0.19% | 2026-06-30 |
| 7 | Simplex Trading, LLC Custodian | $2.07K | <0.01% | 2026-06-30 |
6 filers$4.07M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $1.51M | 37.16% | 2026-06-30 |
| 2 | Simplex Trading, LLC Custodian | $966.69K | 23.74% | 2026-06-30 |
| 3 | IMC-Chicago, LLC Custodian | $573.39K | 14.08% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $525.78K | 12.91% | 2026-06-30 |
| 5 | SIG BROKERAGE, LP | $455.40K | 11.18% | 2026-06-30 |
| 6 | GROUP ONE TRADING LLC Custodian | $37.26K | 0.92% | 2026-06-30 |
ENOV Insider Trading (Form 4)
Latest: 2026-10-01Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Christine Ortiz | Director | Award (A) | +958 | — | EDGAR | |
| 2026-09-08 | Oliver Engert | Chief Administrative Officer | Buy (P) | +2,660 | $18.80 | $50.0K | EDGAR |
| 2026-09-04 | Oliver Engert | Chief Administrative Officer | Buy (P) | +7,598 | $19.74 | $150.0K | EDGAR |
| 2026-09-04 | Damien McDonald | Chief Executive Officer | Buy (P) | +13,035 | $19.15 | $249.6K | EDGAR |
| 2026-07-01 | Christine Ortiz | Director | Award (A) | +846 | — | EDGAR | |
| 2026-06-16 | Oliver Engert | Chief Administrative Officer | Award (A) | +1,000 | $20.99 | $21.0K | EDGAR |
| 2026-06-16 | Oliver Engert | Chief Administrative Officer | Buy (P) | +1,000 | $20.92 | $20.9K | EDGAR |
| 2026-06-15 | Oliver Engert | Chief Administrative Officer | Buy (P) | +1,200 | $21.62 | $25.9K | EDGAR |
| 2026-06-11 | Oliver Engert | Chief Administrative Officer | Buy (P) | +1,000 | $23.00 | $23.0K | EDGAR |
| 2026-06-03 | Oliver Engert | Chief Administrative Officer | Buy (P) | +1,000 | $22.22 | $22.2K | EDGAR |
| 2026-05-21 | Liam Kelly | Director | Award (A) | +9,346 | — | EDGAR | |
| 2026-05-21 | Angela S Lalor | Director | Award (A) | +9,346 | — | EDGAR | |
| 2026-05-21 | Philip Okala | Director | Award (A) | +9,346 | — | EDGAR | |
| 2026-05-21 | Barbara W. Bodem | Director | Award (A) | +9,346 | — | EDGAR | |
| 2026-05-21 | Rajiv Vinnakota | Director | Award (A) | +9,346 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ENOV Insider Holdings
19 insiders · @ $20.81
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Matthew L. Trerotola | CEO | 373,514 | $7.77M | -$1.90M | 11 | 2025-03-11 |
| 2 | Damien McDonald | Chief Executive Officer | 247,077 | $5.14M | $449.6K | 5 | 2026-09-04 |
| 3 | Daniel A Pryor | EVP, Strategy & Business Dev. | 160,449 | $3.34M | -$4.00M | 14 | 2025-12-11 |
| 4 | Phillip Benjamin (ben) Berry | SVP, Chief Financial Officer | 150,822 | $3.14M | -$24.0K | 20 | 2026-05-14 |
| 5 | Brady Shirley | Director | 110,589 | $2.30M | -$775.6K | 16 | 2026-05-21 |
| 6 | Patricia A Lang | SVP, Chief HR Officer | 75,703 | $1.58M | -$211.0K | 14 | 2026-03-10 |
| 7 | Terry D Ross | GROUP PRESIDENT, P&R | 68,477 | $1.43M | $0 | 14 | 2026-03-10 |
| 8 | Oliver Engert | Chief Administrative Officer | 63,898 | $1.33M | $438.0K | 13 | 2026-09-08 |
| 9 | A Clayton Perfall | Director | 56,672 | $1.18M | -$145.6K | 10 | 2026-05-21 |
| 10 | Sharon L Wienbar | Director | 41,946 | $872.9K | $0 | 9 | 2026-05-21 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ENOV Board & Officers
As of SEC filings through Oct 1, 2026Directors 10
- Rajiv Vinnakota · since May 7, 2008
- A Clayton Perfall · since Sep 21, 2010
- Sharon L Wienbar · since Jun 15, 2016
- Liam Kelly · since Jan 1, 2020
- Philip Okala · since Feb 22, 2021
- Angela S Lalor · since Apr 4, 2022
- Barbara W. Bodem · since Apr 4, 2022
- Christine Ortiz · since Apr 4, 2022
- Brady Shirley · listed since Feb 2023
- Damien McDonald · listed since Sep 2025
Officers 8
- Damien McDonald · Chief Executive Officer · since May 12, 2025
- Louis Vogt · Group President, Recon · since Jan 2, 2024
- Terry D Ross · Group President, P&r · since Jan 2, 2024
- Phillip Benjamin (ben) Berry · SVP, Chief Financial Officer · since Jan 1, 2023
- Bradley J Tandy · SVP and Chief Legal Officer · listed since Feb 2024
- Oliver Engert · Chief Administrative Officer · since Jan 5, 2026
- Laura Lee Singleton · SVP, Chief HR Officer · since Apr 3, 2026
- John Kleckner · Principal Accounting Officer · since May 13, 2022
Changes in the last 10 years (39)
| Apr 3, 2026 | Laura Lee Singleton became SVP, Chief HR Officer |
| Jan 5, 2026 | Oliver Engert became Chief Administrative Officer |
| Dec 11, 2025 | Daniel A Pryor reported in an SEC filing no longer being EVP, Strategy & Business Dev. |
| Dec 10, 2025 | The company announced the departure of Patricia A Lang as SVP, Chief HR Officer in an SEC filing |
| Sep 11, 2025 | Damien McDonald first listed as a director in an SEC filing |
| May 12, 2025 | Damien McDonald became Chief Executive Officer |
| Apr 2, 2025 | The company announced the departure of Matthew L. Trerotola from the board in an SEC filing |
| Feb 25, 2025 | The company announced the departure of Matthew L. Trerotola as CEO in an SEC filing |
| Feb 22, 2024 | Matthew L. Trerotola listed as CEO (previously President & CEO) in SEC filings |
| Feb 22, 2024 | Bradley J Tandy listed as SVP and Chief Legal Officer (previously SVP, General Counsel) in SEC filings |
| Jan 2, 2024 | Terry D Ross became Group President, P&r |
| Jan 2, 2024 | Louis Vogt became Group President, Recon |
| Dec 5, 2023 | The company announced the departure of Brady Shirley as Pres. & COO in an SEC filing |
| Mar 14, 2023 | The company announced the departure of Mitchell P Rales from the board in an SEC filing |
| Feb 23, 2023 | Brady Shirley listed as Pres. & COO (previously EVP, Colfax, Pres. & CEO, DJO) in SEC filings |
| Feb 23, 2023 | Brady Shirley first listed as a director in an SEC filing |
| Jan 1, 2023 | Phillip Benjamin (ben) Berry became SVP, Chief Financial Officer |
| Jun 30, 2022 | The company announced the departure of Christopher M Hix as EVP, Chief Financial Officer in an SEC filing |
| May 13, 2022 | John Kleckner became Principal Accounting Officer |
| Apr 4, 2022 | Christine Ortiz became a director |
| Apr 4, 2022 | Barbara W. Bodem became a director |
| Apr 4, 2022 | Angela S Lalor became a director |
| Mar 7, 2022 | The company announced the departure of Thomas Sinnickson Gayner from the board in an SEC filing |
| Mar 7, 2022 | The company announced the departure of Rhonda L Jordan from the board in an SEC filing |
| Mar 7, 2022 | The company announced the departure of Patrick W Allender from the board in an SEC filing |
| Mar 7, 2022 | The company announced the departure of Didier P Teirlinck from the board in an SEC filing |
| Feb 2, 2022 | The company announced the departure of Douglas J. Pitts as Controller, PAO in an SEC filing |
| Feb 22, 2021 | Philip Okala became a director |
| Feb 26, 2020 | Shyam Kambeyanda listed as ESAB President and EVP, Colfax (previously ESAB President and SVP, Colfax) in SEC filings |
| Feb 26, 2020 | Christopher M Hix listed as EVP, Chief Financial Officer (previously SVP, Chief Financial Officer) in SEC filings |
| Feb 14, 2020 | Mitchell P Rales no longer listed as a 10% owner in SEC filings |
| Jan 1, 2020 | Liam Kelly became a director |
| Jul 10, 2019 | Bradley J Tandy became SVP, General Counsel |
| Mar 1, 2019 | Patricia A Lang became SVP, Chief HR Officer |
| Feb 22, 2019 | Douglas J. Pitts became Controller, PAO |
| Feb 22, 2019 | Brady Shirley became EVP, Colfax, Pres. & CEO, DJO |
| Jan 15, 2019 | Mitchell P Rales first listed as a 10% owner in an SEC filing |
| Sep 29, 2017 | Jason MacLean became SVP, CBS & Supply Chain |
| Sep 18, 2017 | Didier P Teirlinck became a director |
Not reported recently (9)
- Shyam Kambeyanda · Last reported as ESAB President and EVP, Colfax in an SEC filing dated Mar 9, 2022
- Jason MacLean · Last reported as SVP, CBS & Supply Chain in an SEC filing dated Nov 10, 2020
- Ian Brander · Last reported as Howden CEO in an SEC filing dated Mar 13, 2019
- Lynn H Clark · Last reported as SVP - Global Human Resources in an SEC filing dated Feb 27, 2019
- Steven M Rales · Last reported as a 10% owner in an SEC filing dated Jan 22, 2019
- A. Lynne Puckett · Last reported as SVP, GC & Secretary in an SEC filing dated Nov 21, 2018
- Stephen Wittig · Last reported as SVP - CBS & Supply Chain in an SEC filing dated Sep 11, 2017
- Darryl Mayhorn · Last reported as SVP, Colfax, Pres. & CEO CFH in an SEC filing dated Aug 3, 2017
- III San W. Orr · Last reported as a director in an SEC filing dated Jun 15, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ENOV Proposed Insider Sales (Form 144)
Latest: 2023-06-02
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | BERRY PHILLIP BENJAMIN (BEN) | Officer | 645 | $34.9K | 2023-06-02 | Merrill Lynch | 10b5-1 | EDGAR |
| 2023-05-17 | MITCHELL P RALES | Director | 8,333 | $465.1K | 2023-05-17 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2023-05-17 | Mitchell P. Rales | Director | 1,088,756 | $60.74M | 2023-05-17 | Monness, Crespi, Hardt & Co., In… | — | EDGAR |
| 2023-05-08 | Vinnakota Rajiv | Director | 1,396 | $79.8K | 2023-05-08 | Merrill Lynch | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
84 ETFs hold ENOV
25 shown · $351.08M total exposure · 0.08% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJR iShares Core S&P Small-Cap ETF | iShares (BlackRock) | 0.07% | $71.0M | $103.1B | 2026-10-20 |
| 2 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.15% | $47.7M | $31.4B | 2026-10-20 |
| 3 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $31.8M | — | 2026-09-30 |
| 4 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.04% | $30.3M | $75.1B | 2026-10-20 |
| 5 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.01% | $22.5M | — | 2026-09-30 |
| 6 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.07% | $19.5M | — | 2026-10-20 |
| 7 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.02% | $14.7M | — | 2026-09-30 |
| 8 | VXF Vanguard Extended Market ETF | Vanguard | 0.01% | $11.9M | — | 2026-09-30 |
| 9 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.04% | $11.4M | — | 2026-10-20 |
| 10 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.08% | $11.1M | $13.7B | 2026-10-20 |
| 11 | SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF | SPDR (State Street) | 0.07% | $10.9M | $15.7B | 2026-10-20 |
| 12 | IJS iShares S&P Small-Cap 600 Value ETF | iShares (BlackRock) | 0.13% | $9.8M | $7.6B | 2026-10-20 |
| 13 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.09% | $8.3M | — | 2026-05-31 |
| 14 | SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF | SPDR (State Street) | 0.13% | $6.2M | $4.7B | 2026-10-20 |
| 15 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.03% | $6.2M | — | 2026-05-31 |
| 16 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.04% | $6.2M | — | 2026-09-30 |
| 17 | IHI iShares U.S. Medical Devices ETF | iShares (BlackRock) | 0.16% | $5.6M | $3.5B | 2026-10-20 |
| 18 | SMLF iShares U.S. Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.11% | $4.6M | $4.2B | 2026-10-20 |
| 19 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.01% | $4.2M | — | 2026-10-20 |
| 20 | VIOO Vanguard S&P Small-Cap 600 ETF | Vanguard | 0.06% | $3.7M | — | 2026-09-30 |
| 21 | RWJ Invesco S&P SmallCap 600 Revenue ETF | Invesco | 0.16% | $3.2M | — | 2026-10-20 |
| 22 | VHT Vanguard Health Care ETF | Vanguard | 0.01% | $3.2M | — | 2026-09-30 |
| 23 | XHE State Street® SPDR® S&P® Health Care Equipment ETF | SPDR (State Street) | 1.70% | $2.5M | $149.3M | 2026-10-20 |
| 24 | TSCV Thrivent Small Cap Value ETF | Nport | 1.23% | $2.3M | — | 2026-06-30 |
| 25 | VIOV Vanguard S&P Small-Cap 600 Value ETF | Vanguard | 0.12% | $2.2M | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-19.27
TTM Revenue
$2.30B
TTM Net Income
$-1.10B
TTM Op. Cash Flow
$270.10M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-07-03 | $582.78M | $-1.19M | $-0.02 | $75.03M |
| Q1 '26 | 2026-04-03 | $589.15M | $-8.76M | $-0.15 | $23.95M |
| Q4 '25 | 2025-12-31 | $575.76M | $-520.59M | $-9.11 | $88.54M |
| Q3 '25 | 2025-10-03 | $548.91M | $-571.15M | $-9.99 | $82.58M |
| Q2 '25 | 2025-07-04 | $564.54M | $-36.74M | $-0.64 | $47.77M |
| Q1 '25 | 2025-04-04 | $558.83M | $-55.97M | $-0.98 | $-1.60M |
| Q4 '24 | 2024-12-31 | $560.98M | $-703.34M | $-12.70 | $88.33M |
| Q3 '24 | 2024-09-27 | $505.22M | $-31.52M | $-0.58 | $53.56M |
| Q2 '24 | 2024-06-28 | $525.16M | $-18.64M | $-0.34 | $21.22M |
| Q1 '24 | 2024-03-29 | $516.27M | $-72.00M | $-1.32 | $-49.60M |
| Q4 '23 | 2023-12-31 | $455.02M | $2.96M | $0.06 | $68.42M |
| Q3 '23 | 2023-09-29 | $417.52M | $-2.88M | $-0.05 | $31.01M |
Q2 2026 • period ending 2026-07-03 • filed 2026-08-06
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
0.81
P/S
0.52
EV/EBITDA
7.55
EV/Sales
1.06
ROE
-74.5%
ROA
-29.3%
Div Yield
0.00%
FCF Yield
22.66%
Debt/Equity
0.84
Current Ratio
—
Market Cap
$1.19B
as of 2026-10-21
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
10.56M
SI % of Float
18.86%
Days to Cover
5.75
Short Vol Ratio
60.9%
Free Float
56.00M
Float %
97.1%
Short interest 2026-09-30 • Short volume 2026-10-21 • Float 2026-08-14